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Abstract
Objective: Assess the global status of newborn/infant hearing screening (NIHS) and its effectiveness in early detection 
and intervention of permanent childhood hearing loss (PCHL).
Design: Individuals potentially involved with NIHS in 196 countries/territories (in the following text referred to as countries) 
received a questionnaire about coverage, strategies, and outcomes of country-specific NIHS programs. 
Study Sample: Questionnaires from 158 countries were returned. 
Results: Thirty-eight percent of the world’s population were reported to have no/minimal screening, 33% reported 
screening more than above 85% of the babies (hereafter referred to as universal newborn hearing screening [UNHS]). 
Mean living standard of countries with UNHS was 10 times higher than in countries with NIHS coverage that was less 
than 10%. Average age at diagnosis of PCHL was 4.6 months for screened children and 34.9 months for non-screened 
children. Average age at start of intervention was 6.9 months for screened children and 35.2 months for non-screened 
children. Methods used for screening included otoacoustic emissions (OAE) in 57% of countries, automated auditory 
brainstem response (AABR) in 11%, and two-step OAE-AABR in 30%. On average, 4.5% of the infants failed the 
screening and 17.2% of those children were reported as lost-to-follow-up. The prevalence of PCHL identified in NIHS 
programs ranged from 0.3–15.0 per 1,000 infants with a median of 1.70.
Conclusions: Newborns with PCHL are more likely to benefit from early identification and intervention in countries where 
NIHS is done. There is a need to invest in NIHS programs, including data collection, in low-income countries.
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Recent estimates by the World Health Organization (WHO) 
indicated growing absolute numbers and prevalences of 
people with disabling hearing loss (Olusanya et al., 2019; 
WHO, 2018a). For children, too, the absolute numbers 
are rising as the world population grows. An estimated 
34 million children currently have disabling hearing loss, 
most of them living in South Asia, Asia Pacific, and Sub-
Saharan Africa (Vos et al., 2016; WHO, 2018a, 2018b, 
2018c; Wilson et al., 2017). These children are in danger 
of impaired language, social, emotional, and academic 
development (Ching et al., 2010; Ching et al., 2018; 
Neumann et al., 2006; Vohr et al., 2011; WHO, 2016; 
Yoshinaga-Itano et al., 1998; Yoshinaga-Itano et al., 2018). 
Universal newborn hearing screening (UNHS) and 
prevention of permanent childhood hearing loss (PCHL) 
are the most effective measures to reduce both the 
prevalence and negative consequences of PCHL, with 
UNHS being very effective for high-income countries (Joint 
Committee on Infant Hearing [JCIH], 2013; Pimperton et 
al., 2016; WHO, 2010; Wilson et al., 2017), and prevention 
expected to show higher relative effects for low-income 
countries (Ching et al., 2010; Ching et al., 2018; Neumann 
et al, 2006; Vohr et al., 2011; Vos et al., 2016; WHO, 2016, 
2020a; Wilson et al., 2017).
According to the recommendations of the Joint Committee 
on Infant Hearing (JCIH, 2007, 2019), babies should 
undergo UNHS before one month of age, those who fail 
the screening should get an audiological diagnosis before 
3 months, and those with PCHL should be enrolled in 
early intervention before 6 months of age (EHDI 1-3-6 
guidelines). If a country is already accomplishing this goal, 
it is advised that this country should strive to achieve the 
new goal of undergoing UNHS by 1 month of age, getting 
an audiological diagnosis before 2 months of age, and 
enrolling in early intervention by 3 months of age (JCIH, 
2019). 
Many studies convincingly demonstrate that children with 
PCHL who were identified and treated early have better 
language and academic outcomes than those with late-
treated hearing loss. This has been shown for general 
language development (Ching et al., 2018, Neumann 
et al., 2006; Yoshinaga-Itano et al., 1998), vocabulary 
(Yoshinaga-Itano et al., 2017), developmental scores, 
and quality-of-life (Korver et al., 2010) for children whose 
hearing loss was identified by NIHS, who were fitted 
early with hearing aids (Tomblin et al., 2015) or cochlear 
implants (Yoshinaga-Itano et al., 2018), or who were 
enrolled in early intervention services (Vohr et al., 2011) 
compared to children without UNHS. Recent large-scale 
epidemiological studies in Australia and Great Britain 
have provided strong evidence of the positive long-term 
outcomes of earlier treatment of infant hearing loss that 
can be achieved through UNHS programs, compared to 
later treatment in terms of language, cognitive, reading, 
and general academic development of hearing impaired 
children and adoslescents (Ching et al., 2018; Kennedy 
et al., 2006; Pimperton et al., 2016; Wake et al., 2016). 
Although the direct and indirect costs and some potential 
negative consequences of UNHS programs have to be 
taken into consideration (Kemper et al., 2000; Zhao et 
al., 2003), studies on parents’ perspectives (Fitzpatrick et 
al., 2007; van der Ploeg et al., 2008; Young & Tattersall, 
2007) and cost-benefit analyses of unaddressed hearing 
loss (WHO, 2017a) showed that advantages of early 
hearing detection and intervention (EHDI) outweigh the 
disadvantages.
In 1995 a WHO resolution called on member states to 
prepare national plans for the prevention and control of 
major causes of avoidable hearing loss, and for early 
detection of hearing loss in babies, toddlers, and children 
(WHO, 1995). Yet, in 2012 only 32 countries reported the 
implementation of such policies, and the WHO bemoaned 
an overall scarcity of epidemiological evidence regarding 
prevalence of hearing loss and ear diseases (WHO, 2013). 
A second resolution by WHO, adopted in 2017, reaffirmed 
the goals of the first and urged member states to collect 
high-quality population-based data on ear diseases and 
hearing loss (WHO, 2017b). So far, no information has 
been gathered about the global situation of NIHS. 
The international study presented here aimed to assess 
the global status of coverage, strategies, and results of 
NIHS programs and child audiology services in as many 
countries or territories (referred to hereafter as countries) 
as possible to serve as a baseline for further evaluation 
and improvement of NIHS effectiveness. In addition, the 
study explores the relation between national economical 
indices and key screening parameters.
Materials and Method
Questionnaire
A 19-item questionnaire, based on an Italian NIHS 
questionnaire (Bubbico et al., 2008), was modified 
to investigate the country-specific status of NIHS. It 
requested information for a reference year about (a) 
percentage of babies who either underwent a newborn 
hearing screening or a screening later in the first year of 
life, relative to the number of live births in the reporting 
year; (b) target population of the screening as either 
covering all babies in a country, state, region, or institution 
(universal screening) or restricted to babies at risk for 
a PCHL (targeted screening); (c) screening method: 
otoacoustic emissions (OAE) or automated auditory 
brainstem response (AABR) alone, or two-stage OAE-
AABR screening (AABR follows immediately if a baby 
has failed an OAE screening), questionnaire-based 
screening, or other screening method; (d) percent of 
all newborns and of screened babies who would have 
needed an audiological assessment because they were 
suspected for a hearing loss, and the percent of babies 
who received such an assessment; (e) number per 1,000 
infants identified with PCHL; (f) the percentage of these 
infants identified with PCHL who had undergone a hearing 
screening; (g) median or mean ages and age ranges of 
diagnosis and onset of early intervention for infants with 
PCHL who either had been screened or not; (h) percent 
of all babies with PCHL who needed an intervention for 
their PCHL, percent of babies with PCHL (both screened 
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and unscreened) who received early intervention, and 
percentage of all babies with PCHL and of screened babies 
with PCHL whose intervention started before 6 months of 
age; (i) whether and when a hearing screening has been 
mandated; (j) when mandated, for which type of screening; 
(k) where the screenings were done and who performed
them; and (l) percent of all birth institutions in a country
which have NIHS programs.
PCHL was defined as unilateral or bilateral permanent 
hearing loss of > 20 dB HL (hearing loss) in the better 
hearing ear, averaged over frequencies 0.5, 1, 2, and 
4 kHz. These criteria meet more recent evidence for 
significant risks children with untreated minimal hearing 
loss face for their speech-language and academic 
development (Olusanya et al., 2019, Winiger et al., 2016). 
Intervention may include (but is not limited to) fitting 
with hearing devices, speech-language therapy, early 
intervention programing by a parent-infant specialist, or 
medical or surgical treatment. In cases where it is unclear 
whether treatment is required, further monitoring also 
counts as intervention.
Participants 
The questionnaire was e-mailed to persons thought to 
be involved in NIHS programs of as many countries 
as possible. Much effort was devoted to identifying 
these key individuals, but for some countries it was 
futile, especially for those with little or no audiological 
services. Many key persons were identified through 
personal knowledge of the authors Katrin Neumann, 
Shelly Chadha, and Karl R. White, all of whom are well-
known in the hearing screening community and who are 
or have been active in it themselves. As Medical Officer 
of the WHO Program for Prevention of Deafness and 
Hearing Loss, Chadha had contact with many national 
programs and key persons. A letter of invitation signed 
by the chairs of several international organizations 
concerned with hearing care (Coalition for Global 
Hearing Health—CGHH, International Association of 
Logopedics and Phoniatrics—IALP, International Society 
of Audiology—ISA, International Working Group on 
Childhood Hearing, Hearing International) accompanied 
the questionnaire. Activities of the Executive Committees 
and members of the above and other organizations such 
as the American Academy of Audiology (AAA), and also 
of non-governmental organizations (NGOs), such as 
Soundseekers and the Christoffel Blindenmission (CBM), 
helped to identify key persons. In French-speaking Africa, 
the network of the Société Oto-rhino-laryngologie (ORL) 
des pays francophones d’Afrique (SORLAF) helped. Where 
available, national or state Newborn Hearing Screening 
centers were contacted. All inquiries were made via e-mail 
by the first author, by telephone, or by addressing contact 
or key persons directly at international conferences. For 
some countries the authors of publications on audiological 
or pediatric topics were contacted with a request for contact 
details of key people in ear and hearing care. Various key 
persons also contacted the first author after she had asked 
professional colleagues to pass on the request. Ministries 
of Health and regional WHO offices were also requested.
The distribution of the questionnaires started in the autumn 
of 2014, and updates were received until January 2019. 
The originally proposed reference year was 2013, but for 
some countries only information from earlier periods was 
available. Because the recruitment of informants lasted 
unexpectedly long, some respondents reported or updated 
their information up to 2018. The returned questionnaires 
were proofed for reliability, completeness, and plausibility. 
To this end, the authors checked whether the responses 
were within the probable range and, where applicable, 
percentages added up to 100%. If study-, hospital-, city-, 
or region-based information was provided additionally or 
alternatively to country-wide data, Appendix B indicates 
the population for which the information was given. In 
cases where data were only available for a subset of a 
country, the respondent was asked how representative the 
data were for the entire country. All questionnaires were 
returned to the respondents with comments and questions 
as needed. For most countries, one or two revisions were 
necessary. To eliminate potential biases, attempts were 
made to have the information confirmed by a second 
person whenever possible.
Statistical Analysis 
In addition to descriptive analyses of the questionnaire 
responses, we investigated the correlations between 
the national average nominal gross domestic product 
per capita (GDP per 1000; the United Nations Statistics 
Division (https://en.wikipedia.org/wiki/List_of_countries_
by_GDP_(nominal)_per_capita); the total health 
expenditure per capita (HE; Global Health Expenditure 
Database [GHED]; https://apps.who.int/nha/database); and 
screening coverage, fail rate, prevalence, mean age at 
diagnosis, and mean age at treatment start.
Because the distributions of fail rate, prevalence, mean 
age at diagnosis, and treatment start were positively 
skewed, as were GDP and HE, they were normalized by a 
log10-transformation. The normalized distributions of GDP 
and HE correlated very highly ( r = .96; N = 182). Because 
both variables were nearly identical, further analyses were 
performed only with GDP.
Results
Of the 196 contacted countries (192 UN Member States 
and Kosovo, Macedonia, Palestine, and Puerto Rico), 
158 provided information. The country-specific results 
of the survey are presented in Appendix B. Because 
some of the information requested in the questionnaire 
(see Materials and Method, subsection Questionnaire) 
was difficult for respondents to access, Appendix B 
presents only the variables which appeared to be the least 
biased ones, leaving out the items (b), (d), (f), (h), (j), (l). 
Nonetheless, for several of these items some justifiable 
results are shown and discussed in the following text. 
For some countries, study-, hospital-, city-, or region-
based information was provided, either exclusively or in 
addition to nationwide information. Appendix B indicates 
the population groups for which information was provided 
on a particular item, and participants were asked about the 
representativeness of their information for the country as a 
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Figure 1
Country Specific Coverage of NIHS Programs  
◼ 85 – 100% screening ◼ 50 – 84% screening ◼ 10 – 49% screening
◼ 1 – 9% screening ◼ 0 – 1% screening  ◼ No Data
Fig 1. Country-specific coverage of NIHS programs. 
◼ 85 – 100% screening ◼ 50 – 84% screening ◼ 10 – 49% screening
◼ 1 – 9% screening ◼ 0 – 1% screening    ◼ No Data
Fig 1. Country-specific coverage of NIHS pr grams. 
whole. Therefore, in several cases, a country-specific row 
in Appendix B contains both—study-, hospital-, or region-
related information, marked with a superscript index, and 
country-wide information. In most cases,  country-specific 
information was included in the statistical analysis, and 
regional information was only included if representativeness 
was ensured, sample sizes were large enough, and 
selection bias was judged by the authors to be small.
For all items of the questionnaire, respondents were asked 
to state whether replies were data-based or estimated. 
Reporting years (with the number of countries or territories 
using that year in parentheses) were 2008 (1), 2009 (1); 
2010 (2), 2011 (6), 2012 (14), 2013 (67), 2014 (75), 2015 
(11), 2016 (15), 2017 (2), and 2018 (3). The number adds 
up to 197 because information was received from some 
countries from several regions, sources, or studies, as 
shown in Appendix B. Number of live births were obtained 
from the national statistic institutions, the United Nations 
(UN) Population Department, UN Demographic Yearbooks, 
or other demographic sources (sources not explicitly 
named in Appendix B; only NIHS-related data sources 
are referenced). When country-wide information was not 
available, fragmentary (or implausible, regional, hospital-
based, or study-based) data were reported separately in 
Appendix B if the samples seemed to be representative for 
specific items.
Appendix B and Figure 1 demonstrate the worldwide 
coverage rates of NIHS programs as reported by 
participants for their country. In Table 1 and Figure 1 the 
coverage of screening within a country was classified into 
five categories, from no or minimal screening (0% to < 
1% of newborns were screened), over three middle-range 
categories, to near/full UNHS (more than 85% of newborns 
were screened). The coverage of screening was bimodally 
distributed, with approximately one third of countries (38% 
of the world’s population) having no/minimal screening and 
another third (33% of the world’s population) having near/
fully implemented UNHS programs. 
Screening coverage is closely associated with average 
living standards and economic well-being, as measured 
by the GDP. Countries with a near/full screening enjoy an 
average of living standard which is 10 times higher than 
that of countries with a screening coverage of < 10%.
Of the more than 32 million babies of the participating 
countries who were screened with the standard screening 
methods (OAE alone, AABR alone, OAE-AABR) within 
a reporting year, more than 21 million (66.5%) were 
screened with OAE alone, about 4.6 million (14.3%) with 
AABR alone, and about 6.2 million (19.2%) with OAE-
AABR (i.e., only if OAE failed was AABR recorded). 
Behavioral tests were reported as used in only 6 countries, 
maternal questionnaires or tympanometry were seldom 
used. OAE was the favored method in 57% of the 
countries and exclusively used in 29%, followed by OAE-
AABR (30% and 21%, respectively), and AABR (11% and 
4%, respectively). 















0% to < 1% 64 32.7 37.63 3.7
1% to 9% 14 7.1 7.42 3.9
10% to 49% 19 9.7 8.33 10.7
50% to 84% 17 8.7 6.72 14.4




41 20.9 6.09 8.6
Sum 196 100 98.78
Table 1
Global Coverage of Newborn and Infant Hearing Screening
Note. The entries do not add up to exactly 100% because 
of not listed dependent and disputed territories. GDP = 
gross domestic product.
Figure 2
Association Between Gross Domestic Product of 
Countries and Coverage of Newborn Infant Hearing 
Screening
Fig. 2. Association between gross domestic product (GDP not log10-normalized for 
illustrative reasons) of countries and coverage of NIHS
Note. Gross domestic product (GDP) not log 10-normal-
ized for illustrative reasons.
The association between coverage of screening and GDP 
(Pearson’s r = .68, GDP not log-transformed for sake of 
clarity) is illustrated in Figure 2 which shows that most data 
points of the scatter plot cluster at the far right or the far 
left side. Countries with a moderate coverage of screening 
(20%–80%) are in the minority. The countries with a 
relatively high coverage show a large variance in GDP, and 
they include countries with a low GDP of < 10 (Belarus, 
China, Kazakhstan, Marshall Islands, Micronesia, and 
Russia).
The log10-normalized GDP correlated negatively with all 
normalized screening parameters, that is with fail rate (r = 
-.30, p = .031), prevalence (r = -.43, p < .001), mean age 
at diagnosis for screened (r = -.30, p = .018) and non-
screened hearing-impaired babies (r = -.43, p = .012), and 
mean age at treatment start for screened (r = -.34, p = 
.016) and non-screened (r = -.54, p = .003) babies.
The mean fail rate of the NIHS programs of all 55 reporting 
countries was 4.5% (SD 5.1, range 0.2–30.8). It was 
statisticially significantly lower (p = .007, Mann-Whitney 
U-test) in the countries with high NIHS coverage of ≥ 85%
(M = 3.1%, SD 2.6, n = 33) and its range was narrower
(0.3–11.6), compared to countries with lower screening
coverage (M = 6.5%, SD 7.0, range 0–98.2, n = 22; all ns
denote number of countries). The mean lost-to-follow-up
rate was 17.2% (SD 25.6, range 0–98.2, n = 51). This rate
was numerically but not statistically significantly lower for
countries with high screening coverage (14.3%, SD 24.9, n
= 30) compared to countries with lower coverage (22.3%,
SD 27.0, n = 20).
The prevalences of PCHL (Appendix B, column 5; Figure 
3) ranged between 0.3 and 15.0 per 1,000 (median: 1.70,
n = 75).
The average age at diagnosis of PCHL for children 
who had undergone hearing screening was 4.6 months 
(SD 3.4, range 0.1–18, n = 61) and the average age 
for non-screened children was 34.9 months (SD 20.4, 
range 12–120, n = 34). The average age at start of early 
intervention for screened children was 6.9 months (SD 4.0, 
range 1.6–24, n = 49), compared to that for non-screened 
children of 35.2 months (SD 18.8, range 12–88.1, n = 28). 
There were large and statistically significant standardized 
mean difference effect sizes (SMDES) between screened 
and non-screened children in age at diagnosis (p < .001, 
SMDES = 7.98 months) and age at therapy start (p < .001, 
SMDES = 7.10 months).
Of the babies identified with PCHL in their birth year for 
this study, 82% on average (n = 59) were identified by 
a hearing screening. From 39 reporting countries, 57% 
of screened babies received early intervention before 6 
months of age.
Whether hearing screening was mandated was answered 
by 98 informants. Of these, 46 reported the presence of a 
mandate and 52 replied there was none. Of the countries 
with mandates, 38 required UNHS, 6 required targeted 
screening, and 2 did not specify. A mandate for hearing 
screening was first legislated in the United States (1992), 
followed by Oman (1996), and China (1999). Although 
governmental mandates seem to be associated with 
screening coverage (Spearman correlation between 
the existence of a mandate and categories of screening 
coverage was rho = .51), there are noticeable exceptions. 
For example, of the 38 high-coverage countries with 
available information, nine had no mandate.
The screening was carried out in birth facilities in 93% of 
the countries. Screening occurred in other places such as 
pediatric, hearing care, immunization, or well-baby clinics 
in 51% of the countries, and in the homes in 14% of the 
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countries (percentages sum to > 100% because a single 
country could have screening done in multiple places).
Professions involved in NIHS were physicians (26% of the 
countries, in 5% exclusively), audiologists, audiological 
staff, or technicians (69% and 16%, respectively), 
nurses, midwives, and nonprofessionals such as trained 
screeners, auxiliary staff, or community health workers 
(69% and 24%, respectively).
Discussion
This survey provides the first data-based information 
about the global status of NIHS programs. According to 
the summarized information provided by respondents, 
which must admittedly be treated with caution because it 
is unverified self-report data, 38% of the world’s population 
had no or minimal screening, and 33% had near/
fully implemented UNHS programs, that is above 85% 
coverage. Because the participating countries represent 
94.8% of the world population, the results of the study are 
a reasonable approximation of the global situation. 
Worldwide, OAE is the most commonly used screening 
method, followed by NIHS programs that use a two-step 
OAE-AABR protocol or those that use AABR alone. This 
finding is consistent with the results of a 2015 study 
involving 39 predominantly European countries (Sloot 
et al., 2015), but differs from a more recent systematic 
review in which the OAE-AABR procedure was the 
method most frequently cited in the published literature 
(Kanji et al., 2018). Yet, our results may be more precise 
because they summarize information from many countries 
with low screening coverage, from which there is little 
published literature and in which OAE is mainly used as 
a screening method. In our study, countries with more 
resources often used a combination of procedures, while 
low-income countries applied predominantly single-step 
procedures, mostly using OAE. Almost all participants 
in our study, who provided separate information on 
screening in neonatal intensive care units (NICUs), used 
AABR, which is consistent with international standards 
(JCIH, 2019) to identify babies with auditory neuropathy 
spectrum disorders, who are more commonly found in 
NICUs (Neumann et al., 2006;  White et al., 2005). The 
advantages and disadvantages of the different screening 
methods are not discussed in detail here, as there is 
extensive literature on this subject (Kanji et al., 2018; 
Nennstiel-Ratzel et al., 2017; Neumann et al., 2006; Sloot 
et al., 2015; White et al., 2005; Wroblewska-Seniuk et al., 
2017). With an average failure rate of 4.5 in our study, 
most screening programs appear to require rescreening 
after a failed screening, as recommended by the JCIH 
(2007, 2019) otherwise the failure rate would be higher 
(Nennstiel-Ratzel et al., 2017).
Figure 3
Country Specific Prevalance Figures of Infant Hearing Loss  
◼ 0–1/1000 ◼ >1-2/1000  ◼ >2-3/1000  ◼ >3-4/1000
◼ >4-5/1000 ◼ >5/1000  ◼ No Data
Fig. 3. Country-specific r valence figures of infant hearing loss.
◼ 0–1/1000  ◼ >1-2/1000  ◼ >2-3/1000  ◼ >3-4/1000
◼ >4-5/1000 ◼ >5/1000    ◼ No Data
Fig. 3. Country-specific prevalence figures of infant hearing loss.
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NIHS is performed mostly in birthing facilities, less in 
out-patient clinics and homes. The survey also provides 
region-specific figures on the prevalences of PCHL, with a 
median of 1.70 per 1,000 infants.
NIHS is associated with a lower average age at which 
a PCHL is diagnosed and treated, at a time when the 
brain structures are still physiologically well accessible for 
treatment (Sloot et al., 2015). The remarkable discrepancy 
between the average ages of screened and non-
screened children at diagnosis of a PCHL and of onset of 
intervention is a strong argument for the implementation 
of NIHS programs. It overrides the counterarguments 
regarding higher direct and indirect costs of a UNHS, 
compared with a targeted screening for children at risk 
(Kemper & Downs, 2000), and of potential negative 
consequences of false positive screenings (Zhau et al., 
2003). 
The discrepancy in age at diagnosis and onset of 
treatment of infant hearing loss between countries with 
and without UNHS programs is reminiscent of the history 
of implementation of UNHS programs in high-income 
countries when screened and non-screened populations 
could be compared. For example, the average age in 
months at diagnosis of hearing loss for screened children 
was 4.2 in the United States, 3.1 in Germany, and 3.9 in 
Austria. However, for children not screened the average 
age in months for diagnosis was 17.5 in the United States, 
39.0 in Germany, and 37.6 in Austria (Harrison et al., 2003; 
Neumann et al., 2006; Weichbold et al., 2005). The age 
in months at the start of treatment was 6.8 in the United 
States, 3.5 in Germany, and 9.4 in Israel for screened 
children and 19.8 in the United States, 39.0 in Germany, 
and 19.0 in Israel for non-screened children (Harrison et 
al., 2003; Neumann et al., 2006; Wasser et al., 2019). 
The average age at diagnosis of 4.6 months and start 
of early intervention of 6.9 months in the present study 
approaches the goals of the EHDI 1-3-6 guidelines, but 
does not quite reach them. The implementation of NIHS 
programs and the associated reduction in the average age 
of diagnosis and therapy start in many countries around 
the world can be seen as positive and can be expected 
to produce significantly better language and academic 
outcome and benefit from hearing devices of the screened 
children with PCHL than for later ages (JCIH 2007, Kral & 
Sharma, 2012; Yoshinaga-Itano et al., 2017; Yoshinaga-
Itano et al., 2018). However, the fact that only just over half 
of all babies with PCHL examined in our study received 
early intervention before the age of 6 months remains a 
critical point. Yoshinago-Itano et al. (2017, 2018) have 
shown that young children with hearing loss who are 
identified before 3 months of age and begin receiving early 
intervention before 6 months of age have better outcomes 
than similar children who are identified and begin 
intervention at later ages. NIHS programs should thus 
work toward meeting these critical time marks, which cast 
a new light on the crucial length of the sensitive periods 
of auditory pathway maturation for the development of 
speech understanding and acquisition of spoken language 
(Kral et al., 2019).
For 38 of 196 contacted countries (mostly countries 
with very limited audiological services) no key informant 
could be identified. For low-income countries, responses 
frequently came from non-governmental organizations or 
from domestic/foreign researchers who had conducted 
studies or provided services in that country.
The lack of regional or national NIHS databases and 
regular data collection impacts the quality of many 
screening programs. Such a lack is associated with a 
dearth of tracking programs to refer babies who have failed 
the screening to audiological diagnostic and treatment 
services. Without tracking, the lost-to-follow-up rate is 
usually high or simply unknown. This is also illustrated 
by the finding that in countries with near/fully functioning 
UNHS programs lost-to-follow-up rates are on average 
7% lower than in countries with lower UNHS coverage. 
Of the 27 countries that reported trustworthy lost-to-
follow-up rates, 13 (48%) were above 30%, the criterion 
based on the recommendations of the JCIH (American 
Speech-Language-Hearing Association, 2019; JCIH, 
2007) to achieve a return-for-follow-up of 70% of infants 
or more. This result is in close agreement with that of the 
meta-analysis of Bussé et al. (2020), where lost-to-follow-
up rates from 18 out of 41 (44%) studies were above 
30%, which means that nearly half of NIHS programs 
lose too many children with suspected hearing loss for 
diagnosis. In a systematic review by Ravi et al. (2016), 
educational disparity and parents’ lack of knowledge were 
associated with high lost-to-follow-up rates, and the most 
commonly used strategy to overcome the latter was to use 
appropriate data management systems.
It is impossible to know how extensive or complete an 
NIHS program is without a database. For example, several 
Arab, South East Asian, and Latin American countries do 
hearing screening in many institutions, but were unable to 
provide information about relevant screening parameters 
due to the lack of data. Respondents from such countries 
often reported only hospital-based data that may or may 
not be representative for the whole country. The lack of 
data becomes even more serious when there is no hearing 
screening at all. Usually in such cases no information is 
available on how many children in a birth cohort would 
have needed diagnosis, how many are suspected of 
having a hearing loss, how many actually have one, how 
many have received diagnosis or therapy (therefore these 
items of the questionnaire are not shown in Appendix B), 
and at what age (Appendix B, columns 6 and 7).
A full or nearly full UNHS was implemented in the USA, 
Uruguay, most European countries, Israel, Kazakhstan, 
Oman, Qatar, South Korea, Seychelles, Australia, New 
Zealand, and in Pacific Island nations that are territories 
of the USA. Other countries such as Canada, Mongolia, 
Panama, and China have implemented large-scale NIHS 
programs even though they are not universal in the entire 
country. Interestingly, these countries are by no means 
all high-income countries. We therefore assume that the 
implementation of NIHS depends not only on national 
wealth but also on other factors such as awareness and 
attention to the problem of infant hearing health among 
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policy makers and health care professionals in a country. 
The importance of such factors is supported by the fact 
that some countries with high coverage rates do not have 
a governmental mandate for screening, indicating that 
a mandate might be helpful for the implementation of a 
nationwide NIHS program, but is not necessary.
The dramatically lower living standard of countries with low 
screening coverage, compared to countries with a high 
coverage, is aggravated by the fact that 80% of people 
with disabling hearing loss live in low- or middle-income 
countries (Lancet, 2017), where poor birth conditions and 
lack of vaccination programs contribute substantially to the 
incidence of PCHL (WHO, 2018b). This imbalance is also 
reflected in the fact that the global production of hearing 
aids covers less than 3% of the needs in these countries 
(WHO, 2011). 
Less developed NIHS programs often have relatively high 
lost-to-follow-up rates. Reasons often mentioned for not 
coming to follow-up appointments include distance from 
the hospital, difficulties with transport, fear and uncertainty 
about the referral hospital, procedural problems, lack of 
awareness and understanding about hearing loss, and 
inadequate visibility and availability of services (WHO, 
2011). The statistically significant negative correlation of 
GDP, and thus HE, with the prevalence of early childhood 
hearing loss may be related to the fact that its prevention 
is not sufficiently effective in low income countries. For 
example, infections of pregnant women and newborns 
are more common, education about the consequences 
of parental consanguinity is less frequent, and the quality 
of obstetrics and care for premature babies is not as 
developed as in high-income countries (WHO, 2016). 
The negative correlation with the mean age of diagnosis 
and treatment start of non-screened hearing impaired 
children may be due to the low political will, limited public 
awareness, low prioritization of childhood hearing loss 
as a hidden disease, and the low or simply impossible 
allocation of resources to this condition in low-income 
countries (WHO, 2016; 2017a). The negative association 
with the mean age of diagnosis and treatment start of 
screened infants with hearing loss may be explained by 
the low standards of NIHS that is mostly sporadic in low 
resource countries where audiological diagnostic and 
treatment services are often lacking (Bright et al., 2017; 
Olusanya, 2012; Olusanya et al., 2009; Olusanya et al., 
2014).
The prevalence reports of PCHL were of the expected 
magnitude (median 1.70 per 1000; range 0.3–15; 75 
countries) and are close to those of a recent systematic 
review and meta-analysis (overall prevalence 2.21 per 
1000; range 1–6; 35 included studies; Bussé et al., 2020). 
The highest prevalences were reported from regions 
where the proportion of inherited forms of sensorineural 
hearing loss is relatively high due to traditional high 
parental consanguinity (e.g., Pakistan, Egypt, Algeria, 
Jordan, Turkey). This is in line with the findings of the 
UK Millennium Cohort Study, where the risks of having 
a parent-reported PCHL at the age of 11 was increased, 
among others, in children of Pakistani or Bangladeshi 
ethnicity (Butcher et al., 2019). Genetic counseling and 
health education is important to reduce these numbers 
(WHO, 2016; Smith et al., 2005).
In high-income countries NIHS is predominantly hospital-
based. But other settings have been shown to be 
successful, too, such as screenings performed in the 
parents’ homes or in well-baby clinics (van der Ploeg et 
al., 2012), or as community-based programs in primary 
health care clinics (Friderichs et al., 2012), screening 
camps (Bright et al., 2017), or in conjunction with 
childhood vaccination programs (Friderichs et al., 2012; 
Olusanya et al., 2009). Community-based infant hearing 
screening models may be even more cost-effective than 
hospital-based models, as shown for a program in Nigeria 
(Olusanya et al., 2009). Worldwide, screening is mostly 
performed by nurses and trained non-professionals.
To make a UNHS program effective and to enable inter-
program comparability, it is necessary to apply quality 
indicators and benchmarks of the screening, which have 
been published in position papers of the JCIH (2007, 
2019) and the WHO (2010) and are specified in a recently 
published checklist (Mincarone et al., 2015). Critical points 
that contribute to the quality of a program are: Definition 
of the screening targets (e.g., bilateral or unilateral 
hearing loss, detection threshold); unified definition of 
risk populations and classification of hearing loss; high 
coverage rate of the screening; keeping lost-to-follow-up 
rates low; timely completion of screening, diagnosis, and 
start of intervention, and continuous quality control and 
monitoring of the screening process.
Limitations
Because this is the first time a global assessment of NIHS 
programs has been done, there are understandably a 
number of limitations that need to be addressed in future 
efforts of a similar nature. The reporting period was 
originally planned for 2013. However, the time consuming 
data collection prolonged this period and several 
countries updated their information, whereas others did 
not. Hence, for some countries recent developments are 
not taken into account, which may have caused biases. 
The reported data were often self-reported estimates 
that occasionally tended to be optimistic. For example, 
from the reported data a lost-to-follow-up rate of 0% 
was calculated for 24 out of 51 countries, which is highly 
unlikely. Where data seemed implausible to the authors 
after checking with the respondents, they were omitted 
from calculations. Therefore, the number of reported data 
points per item shown in Appendix B frequently differs 
from the sample size of the calculated overall outcomes. 
Moreover, it has been difficult to collect data from some 
large countries, such as India, which is a subcontinent 
in itself, and the data often refer to local screening 
programs or extrapolations from them. The authors have 
tried to extract information from the available data that 
is as representative as possible for a country. Whenever 
possible, the information given was confirmed by a second 
person or institution. 
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Outlook
In spite of these limitations, this survey provided additional 
evidence for the effectiveness of NIHS programs 
worldwide in reducing the age at which early intervention 
starts for PCHL, which should lead to improved language 
and academic outcomes for the children concerned. 
Growing numbers of children with PCHL call for an 
investment in high-quality UNHS programs (Neumann et 
al., 2019). The 2017 WHO resolution urges member states 
“…to collect high-quality population-based data on ear 
diseases and hearing loss in order to develop evidence-
based strategies and policies” (WHO, 2017b, p. 2). This 
survey is a first step to do so in the field of NIHS. Further 
regular data collection is an urgent need to enhance the 
quality of NIHS programs. The survey demonstrates that 
there is a need to invest in NIHS programs, particularly in 
low-income countries.
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Appendix B 
Country-Specific Information on Newborn Infant Hearing Screening (NIHS) as Retrieved by Informant Replies
Region Reporting year*: # of live births % of newborns screened Fail rate
Babies with 
PCHL1 per 1000
Mean age in months 
(range) at diagnosis of 
screened
Mean age in 
months at 




Where was screening done? 






Albania 2013: 35,750 3.6% UNHS no 2 private hospitals
MH2 100% OAE 20% audiologists, 80% nurses
Austria 2012: 78,952 88% UNHS 2.3 1.0 8.7 (0.2–145) 8.7 (0.2–145) no 95% birth facilities, 5% ENT clinics/practice
SA3, TCHR4 90% OAE, 10% OAE-AABR 0.0 37.1 (0.9–188) 46 (0.9–188) 10% physicians, 20% audiologists, 65% nurses, 5% midwives 
Belarus 2013: 116,073 94.6% UNHS 0.7 6 (1–17) 6 yes, UNHS/2008 94.6% birth facilities, 4% other medical institutions




88.9%  UNHS 2.8 1.7 1.8 (0.4–6.1) (Flanders) 1.8 (0.4–6.1) (Flanders)
yes, targeted/not 
reported
3.6% birth facilities, 29.9% homes, 51,6% 
welfare baby clinics, 14,9% local districts 
houses 
KG6, DSN7, ZOG8 61.4% AABR, 38.6% OAE-AABR 42.3 3.6% audiologists, 96.4% nurses/CHW9
2013: 3,88310 80.9% UNHS 0.2 1.3 7.5 (6-9) 10 no 100% birth facilities
BR11, ENT Dept12 100% OAE-AABR 0.0 30 (24–36) 33 (29–39) 100% nurses
2013: 66,578 5% UNHS 2.0 no
90% OAE, 10% OAE-AABR
2011: 41,200 99% UNHS 0.6 1.0 5 (1–19) 5.2 (1–19) yes, UNHS/ 2006 100% birth facilities
CAEHD13, CUHZ14 97% OAE, 3% OAE-AABR 16.7 100% nurses
2013: 9,341 0.4 2.3 1 (0.5-2) 4 no 10% birth facilities, 90% outpatient (community centers)
NGO15, CUNHS16
20% physicians, 10% audiologists, 70% 
nurses
2013: 106,751 81% UNHS yes, UNHS/ 2012 90% birth facilities, 10% ENT  & pediatric departments
CSO17 90% OAE, 10% OAE-AABR
20% physicians, 10% audiologists, 70% 
nurses
2013: 12,604 99.1% UNHS 1.7 1.7 0.7 (0–2) 7.6 yes, UNHS/ 2005 100% birth facilities
EPF19 88% AABR, 12% OAE-AABR 0.0 30% nurses, 70% midwives
2012: 14,056 99.3% UNHS 0.2 1.7 6.7 (0–10) 6.7 yes, UNHS/ 2004 87.5% birth facilities, 12.5% child hospitals
TUC20 100% OAE-AABR 0.0 100% midwives
2013: 59,856 96% UNHS 1.2 1.2 6 (3–36) yes, UNHS/not reported 100% birth facilities
NIHW21, ES22, MHHUCH23 100% OAE-AABR 0.0 100% nurses
2016: 744,296 97.6% UNHS 1.5 1.0 yes, UNHS 2012 100% birth facilities
AFDPHE24, ARS25 36% OAE, 64% OAE-AABR 37.1
10% audiologists, 30% midwives, 60% 
auxiliary nurses
2013: 682,069 96% UNHS 5.5 1.3–1.7 (bilat.)26; 4 (0–46)26 5 (1–46)26 yes, UNHS/2008
76% birth facilities, 4% pedaudiology 
institution, ENT & pediatric practice, 20% 
NICUs28
REGNHS26, SoH 27
38% OAE, 42% OAE-AABR & 20% 
AABR, NICUs28: 83.8% OAE-AABR or 
AABR26
20.8
2.7 (uni- and 
bilat)26
25 28 1% physicians, 5% audiologists, 92% nurses, 2% midwives 
2013: 94,134 30% UNHS 4.0 0.5 5 (2–11) 5 no 100% birth facilities
95% OAE, 5% OAE-AABR 87.5 25 (12–42) 25 (12–42) 100% physicians
2013: 88,689 >50% UNHS yes, UNHS/2009 100% birth facilities
100% OAE 30% audiologists, 70% nurses
2013: 4,323 92% UNHS 0.4 0.9 1.2 (0–3) 2 no 89% birth facilities, 11% NHSI29
NHSI29, DH30 100% OAE 0.0 21% audiologists, 78% nurses, 1% midwives
2013: 68,930 99.8% UNHS 3.1 1.2 0.13 (0–12) no, NHS/2011 99.4% birth facilities, 0.6% homes
ESP31
84.6% OAE, 15.4% OAE-AABR 
(NICU28)
3.2 21% audiologists, 78% nurses, 1% midwives
2011: 527,308 79.7% UNHS 3.8 2.0 5 (3–7) 12 yes, UNHS/not reported 100% birth facilities
NSNHS32 91% OAE, 8% OAE-AABR, 1% AABR 0.0 14 (9–18) 18 (12–24)
11% pediatricians, 2% audiologists, 72% 
nurses, 11% technicians, 4% CHW9
2013: 20,251 95% UNHS 5.3 2.0 11.5 (1–24) 8 yes, UNHS/not reported 100% birth facilities
NIS33, LCHC34 95% OAE, 5% OAE-AABR 0.0 36 (12–48) 22 (3–60) 100% nurses
2013: 339 no newborn hearing screening 
2013: 3,97735 77% UNHS 5.6 2.9 2 (1–8) nd yes, UNHS/2014 100% birth facilities
KCP36 100% OAE 0.0 100% nurses
2013: 6,889 98.6% UNHS 4.2 0.7 8.25 (4–18) 12.75 (6–21) yes, UNHS 2007 85% birth facilities, 15% MH2
MH2 96.8% OAE, 3.2% AABR (NICU28) 22.0 3 (3–6) 6 (3–18) 100% audiologists
2013: 23,138 no screening
2013: 4,127 10% UNHS 1.5 0.5 (0.1–1.0) no 10% birth facilities, 90% ENTOP37
100% OAE 18 (screen+non-screen) 20 (screen+non-screen)
10% physicians, 50% audiologists, 40% 
auxiliary nurses
2017: 34,060 11.70% 5 (1–9) 10 (4–16)38 no
70% birth facilities, 15% homes, 15% other 
outpatient places
65% OAE-AABR or questionnaires 55 (26–84) 72 (24–84)39 
90% audiologists, 5% nurses, 1% midwives, 
4% CHW9
2013: 964 95% yes, UNHS/2014 100% birth facilities
90% OAE, 5% AABR, 5% OAE–AABR 10% nurses, 90% midwives
2013: 171,341, 167,490a,39 99.4%39 0.3 1.239,44 1.7 5.3
yes UNHS/2015 
(revised version) 75% at homes, 25% well baby clinics
CBS40, NSDSK41, TNO42, 
RIVM43
99.7%39 OAE-AABR, 0.3%39 AABR 0.0 100% CHW9
2014: 59,084, 4,024a,47 95% 5.3 2.0 5 (0.5–10) 6 yes, UNHS/2008 100% birth facilities
95–97% TEOAE, 3–5% TEOAE-AABR 0.0 5% audiologists, 95% nurses
2013: 368,576 95.80% 7.5 3.0 3 (0–17) 4.2 yes, UNHS/not reported 98% birth facilities, 2% audiology centers
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Appendix B (cont.) 
Country-Specific Information on Newborn Infant Hearing Screening (NIHS) as Retrieved by Informant Replies
Region Reporting year*: # of live births % of newborns screened Fail rate
Babies with 
PCHL1 per 1000
Mean age in months 
(range) at diagnosis of 
screened
Mean age in 
months at 




Where was screening done? 






(2005–2010) sporadic no 2 audiology practices
AM76 100% OAE 100% audiologists
2017: 37,699 62.40% 3.2 1.2 6 6 yes, UNHS/not reported 100% birth facilities
100% OAE 17.1 14 16 20% audiologists, 80% nurses
2014: 21,037 (2015) Hospital-based
2013: 330,000 (2010) sporadic no
AEC77 100% OAE 36 (6–216) 36 (6–216)
100 mid-level primary ear and hearing care 
clinicians
2013: 16,400,000 69% UNHS, 30% later, 0.1% targeted 8.7 2 yes/1999 100% birth facilities
NRMCH78 90% OAE, 5% AABR, 5% OAE-AABR 100% nurses
2013: 57,878 39.2% UNHS 8.9 0.3
NSOG79 100% OAE 0.0 100% researchers
2014: 27,271,000 
(2005–2010) <1%, regional UNHS
80 10.2480 5–6 no
SIDK80 100% OAE80
5% physicians, 50% audiologists, 10% nurses, 
15% trained screeners, 20% CHW9, junior 
public health nurses80
2012: 4,464,000 
(2005–2010) sporadic 1.0 3 (6–9) 6 no 100% birth facilities
MH2, IORLS81
30% OAE, 10% OAE-AABR, 60% 
OAE-ABR click 19.6 28 (18–36) 36 (18–48) 90% physicians, 10% audioogists
2015 & 2018 sporadic 9.5 0.5 (2 studies) yes, UNHS/2017 100% audiology centers
about 1,079,000           
7326 (2 studies) 100% OAE 100% physicians
2013: 1,427,653 66.4%, 63% UNHS, 3.4% targeted 2.6 1 (1–3) 6 no 95% birth facilities, 5% outpatient centers
SWOI82, ENTHNRC83 20% OAE, 80% OAE-AABR 42 (24–60) 46 (28–64)
65% audiologists, 10% nurses, 5% midwives, 
20% CHW9
2012: 170,940 99.1% UNHS 0.885 3.7 (0–39.3)86 9.486
2010 directive 
given for UNHS 100% birth facilities
NSI84 100% OAE-AABR 9.587 19.3
20% audiologists, 80% trained screeners & 
biotechnic
2013: 1,029,816 62% UNHS 1.5 1 1–3 (0.25–14.0) 6 no 98% birth facilities, 2% pediatric clinics
SORLJ88, SJAOG89, 
SOP90
28% OAE, 63% AABR, 9% OAE-
AABR 0.0 48 (4-nd)
8% physicians, 1% audiologists, 39% nurses, 
35% midwives, 17% technicians
2013: 178,000 68%, 67% UNHS, 1% targeted 11.8 6.0 4.3 (0.2–0.9) 4.6 no 90% birth facilities, 10% other
MH2, UNHSPJ91, SACJ92 99% OAE, 1% AABR 37.5 1.6 (0.6–5.4) 1.8 (0.6–8) 30% audiologists, 70% nurses
2013: 363,123 85.2% UNHS yes, UNHS/2009 100% birth facilities
MH2 100% OAE
2013: 356,000 no screening no
AEI93
2014: 435,435 90.1%, 86.7 UNHS, 3.4% targeted94,95 1.7 7.194 3(1.5–6)
directive given for 
UNHS 98% birth facilities, 2% homes/other places
9.8% OAE, 90.2 AABR, 72% later94 80.7
19.3% physicians, 29% audiologists, 51.7% 
speech pathologists





3.6% UNHS, 7.6% targeted 1.4 no 100% hospitals96
52.4% AABR, 47.6% OAE-AABR96 97.4 25% audiologists, 75% nurses96
2018: 78,444
Mongolia total 2013: 60% UNHS, 










NCMCH97 100% AABR 30 100% audiologists
2014: 836,961 20.2%, 14.8% UNHS
98, 5.4% 
targeted98
3.4 35.098 2 (1–3) 2 no 100% birth facilities
HARNUCWHM98 100% OAE-AABR 0.0 36 36 50% physicians, 50% audiologists
2012: 593,300 sporadic, 4% at risk 12 (3–36) no birth facilities, outpatient, homes
IOMK99 100% OAE-AABR99 36 (12–60)99 12 (nd)99 100% audiologists99
2014: 71,650 96,6% UNHS, targeted 0.04% 1.7 1.0 6 (1–12) nd (6–36) yes, UNHS/1996 99% birth facilities, 1% mother–child clinics
OECP100 100% OAE 0.0 nurses, 90% midwives
2013: 4,666,000 
(2005–2010) 2% UNHS, 3% later, 2% targeted 2.9 15.0 18 (3–24) 24 no 10% birth facilities, 90% audiology clinics
PDHS101 
70% OAE, 5% AABR, 25% OAE-
AABR 30 (3–5) 36 100% audiologists
2011: 121,493 no UNHS, 3% later 4.7 no birth facilities, outpatient







2012: 18,067 97% UNHS 3.1 1.8 0.5 (0.3–2) 2–3 yes, UNHS/2003 100% birth facilities, private clinics
HMC104 100% OAE-AABR 0.0 3 (3–8) 3 (3–8) 100% audio-physicians
2014: 569,000 
(2005–2010) hospital-based UNHS or targeted 1.8
105 not reported
2014: 187,000 
(2005–2010) 1% UNHS, 0.5% later, 0.5% targeted 2 (1–12) 2 no
33% physicians, 33% audiologists, 33% 
nurses
NMCT106 100% OAE-AABR 1 (1–1) 2 (1–24)
2014: 748,081 (2013) estimated 70% hospital-based UNHS no most provincial/regional hospitals
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Region Reporting year*: # of live births % of newborns screened Fail rate
Babies with 
PCHL1 per 1000
Mean age in months 
(range) at diagnosis of 
screened
Mean age in 
months at 




Where was screening done? 





2013: 679,519 1.5–1.8(1–36) yes, UNHS/2013 48% neonatologists, 42% audiologists, 8.5% nurses, 1,5% others
IHU107
2013: 1,500,000 1–3% UNHS, 5% targeted 4 24 (3.15) 12 no 10% birth facilities
CHHCMC108 100% OAE, 100% behavioral test 24 (3–40) 25% physicians, 75% nurses
2013: 383,800 64% UNHS, 5% later, 4% targeted 1.9 2.0 3 (1–12) 5 no 85% birth facilities, 15% community health centers
PLPD109 3% OAE, 9% AABR, 88% OAE-AABR 8.3
5% audiologists, 10% nurses, 1% midwives, 
84% CHW9
2013: 2,243,352 23.3% UNHS110 2.5111 12 (6–20)111
yes, targeted/not 
reported 100% birth facilities
CONADIS110 100% OAE 35112 33% physicians, 67% nurses
2016: 3,830,526 94.8% UNHS, 3.8% later 1.6 1.7 yes, UNHS in 43 of 50 states 98% birth facilities, 2% homes
CDC113, USDHHS 114
40% OAE, 50% AABR, 10% OAE-
AABR 53.3
2013: 754,603 
12% (Arg), 89% UNHS, 20% later, 1% 
targeted115





80% birth facilities, 20% community & private 
centers
3,983a,115
 100% OAE-AABR (well babies), 100% 
AABR (at-risk babies)115
0.0 100% audiologists
2014: 2,902 targeted pediatricians, nurses
100% OAE
2013: 313,638 58.1%, 23.3% UNHS, 31.7% later, 3.1% targeted 4.1 not reported 100% birth facilities




Brazil total: 24%116 UNHS; São Paulo: 
97.7%117 UNHS
0.2117 yes, UNHS/2010
hospitals, maternity wards, primary health 
care centers, hearing health care units
MH2,116, MHSP117 
Brazil total: OAE, AABR, OAE-AABR; 
São Paulo: 100% OAE-AABR (well 
babies 87.9%), 100% AABR (at-risk 
babies 9.8%)117
43.5117 100% audiologists
2016: 231,749 MH2, 
HPH118
39% UNHS, 1% targeted 5.0 3.0 1 (0.7–3)118 4.4 (max. 11.2)118 yes, targeted /2005 100% hospitals
80% OAE, 20% AABR 0.0 24 30 94% audiologists, 6% nurses
2013: 764,000 
(2010–2015) 2.3% UNHS, 2% later, 2% targeted
119 15.9119 4.0119 2 (0–36) 12
yes, UNHS/not 
reported 10% birth facilities, 90% outpatient places
FSFB119
8.1% OAE, 86.5% AABR, 5.4% OAE-
AABR, pediatric clinic child history 
10%119
40.0119 48 (48–72) 36 (48–72) 1% physicians, 99% audiologists
2013: 70,550 Not reported yes, UNHS/2013 80% birth facilities, 20% outpatient places
CCSS120 100% OAE 10% physicians, 90% audiologists
2012: 150,581 0.09% targeted (preterms) no
100% OAE audiologists
2013: 387,342 0.09% targeted121 5.6 2.9121 12 12–24 no
1% birth facilities, 99% outpatient (2 audiology 
clinics, 1 pediatric clinic)
FSQE121 100% OAE 40.0 36 (1–96) 48 (18–72) 1% pediatricians, 99% audiologists 
2012: 39,553 sporadic no various places 
100% OAE-AABR mainly audiologists
2013: 132,165 (2010)
65%, 40% UNHS, 20% later, 5% 
targeted122
30.8 6.0122 1 (0–10) 48122 no 20% birth facilities, 80% diagnostic centers
private hospital122 100% OAE (NHS), 50% pediatr122 50.0 60 (36–96) 30122
10% physicians, 1% audiologists, 89% trained 
screeners
2013: 73,804
82.5%, 66% UNHS, 15% later, 1,5% 
targeted123
4.9 1.0123 6 (2–12)123 7.9123 no 93.5% birth facilities, 6.5% private clinics
SDHNPC123
92% OAE, 4% AABR, 4% OAE-
AABR123 (NHS), 2% tymp & AABR
75.0 90 (24–156)123 36 (24–156)123
96% audiologists, 4% neurophysiological 
technicians
2013: 38,986 97.5% UNHS 2.8 1.4124 yes UNHS/2003 98% birth facilities, 2% extramural
PRDH124
100% OAE-AABR (well babies), 100% 
AABR (NICUs28)
70% audiologists, 30% trained nurses
2010–2015: 619,000 0.005% targeted no
70% OAE, 30% OAE-AABR
2010–2015: 49,000 99% UNHS, 0.06% targeted 0.5 0.7 6 (4–8) 6 yes UNHS/not reported 99.9% birth facilities, 0.1% homes
97% OAE, 3% OAE-AABR 0.0 10% physicians, 25% audiologists, 65% nurses
2017: 309,142 (2013) 97% UNHS 0.9 1–1.8 (medians according to states)
no, but UNHS is 
fully funded 
government policy
>90% birth facilities, <1% homes, <10% 
outpatient clinics & community health centers
various sources125 100% AABR
state-employed hearing screeners, nurses, or 
midwives
2011: 977126 96.8% UNHS 11.6 0.0 no
CDC & USDHH126 98.2
2013: 2,555 (2018) 91.60% 1.4 no
100% OAE-AABR
2013: 59,245 88.2% UNHS 2.2 1.1 2.1 (<1–11)/nd
no, but nationally 
managed UNHS & 
Early Intervention 
Program
Maternity hospitals, outpatient clinics, homes 
(rarely)
NNHSDB127
84% OAE-AABR (well babies), 16% 
AABR (at-risk) 15.8 Certified  newborn hearing screeners
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Appendix B (cont.) 
Country-Specific Information on Newborn Infant Hearing Screening (NIHS) as Retrieved by Informant Replies
ABR = automated auditory brainstem response; NHS = newborn hearing screening; OAE = otoacoustic emissions; TEOAE = transitory evoked otoacoustic 
emissions; UNHS = universal newborn hearing screening
*Pertains to all questionnaire data; reporting year for # of life births is frequently different; **data on life births from national statistical institutes, UN Population
Department, UN Demographic Yearbooks, or GeoStat; only NIHS-related data sources indicated by superscript; athis birth number refers to a subpopulation,
upon which the following data about this country are based.
1permanent childhood hearing loss, 2Ministry of Health/Healthcare, 3Statistik Austria (www.statistik.at), 4Tyrolean Childhood Hearing Loss Register, 5National 
Centre of Otorhinolaryngology, 6Kind & Gezin, 7Dépistage de la surdité chez les noveau-nés, 8Zorg en Gezondheid, 9community health workers, 10data from two 
of seven screening maternity clinics of a total of 13 maternity clinics, 11birth registry, 12ENT department University Hospital Banja Luka, 13Croatian Association 
for Early Hearing Diagnostics, 14Children’s University Hospital Zagreb, 15non-governmental organization responsible for all pre-and neonatal screenings, 
16Cyprus UNHS, 17Czech Statistical Office, 18Central Denmark Region (1.25 mio inhabitants, 20% of Danish population), 19electronic patient file system EPF, 
used to register all patients in a region including screening and diagnostics, 20Tartu University Clinic, 21The National Institute for Health and Welfare, 22etiology 
study, 23Maternity Hospital of the Helsinki University Central Hospital, 24Association Française pour le Dépistage et la Prévention des Handicaps de l’Enfant, 
25Agences Régionales de Santé, 26Report on evaluation of the German newborn hearing screening 2011/2012, 27data from a population-based study with 
17,439 screened newborns, performed in the Federal State of Hesse (Neumann et al. 2006), 28neonatal intensive care unit, 29The National Hearing and 
Speech Institute of Iceland, 30Directorate of Health, 31E-Screener Plus, 32nationwide surveys on NHS, 33National Institute of Statistics, 34Latvia Children Hearing 
Center, 35data available only of the Kaunas region, but representative, 36Kaunas Center of Perinatology, data only for Kaunas region, 37Ear, Nose, and Throat 
outpatient, 38data from Republican Center of Audiology , 39data without NICU babies, 40Centraal Bureau voor de Statistiek, 41Nederlandse Stichting voor het 
Dove en Slechthorende Kind, 42Netherlands Organisation for Applied Scientific Research, 43Rijksinstituut voor Volksgezondheid en Milieu, 44detection threshold 
NHS 40 dB, 45Statistics Norway, 46Polish Universal Neonatal Hearing Screening Program, 47data from 27 out of all 50 maternity hospitals, 48UNHS National 
Program, 49screening obligatory only for institutions included in the pilot National UNHS Program, 50auditory steady-state response, 51database of pediatric Ear, 
Nose and Throat Department, 52Principado de Asturias government registry, 53data from Asturias region (7445 babies), 54national survey 2012, 55study of the 
University Hospital Zurich 2005-2010, 56data from Çorlu State Hospital region of 11,575 neonates screened between Sept. 2009 and November 2012, 57data 
from April 1, 2012, to March 31, 2013, national screening IT system, 58national screening database, 59Registre des naissance de la clinique Sbihi de Tizi Ouzou 
and 60Registre des naissances de la wilaya de Tizi Ouzou, 61Farid Boudjenah doctoral thesis ”Dépistage et réhabilitation de la surdité et néonatal au CHU de 
Tizi-Ouzou: stratégies et résultats”, 62hospital statistics, 63Ecoles de sourds de Cotonou, 64Centre National Hospitalier Universitaire Hubert K. Maga Cotonou, 
65data from a thesis, 66data from study, 67data from Ain Shams University Hospital, 68data from Hearing assessment center Korle Bu Teaching Hospital Accra, 
the only institution that performs UNHS in Ghana, 69only screenings for 321 children (0.5-0.6yrs) from 1 clinic reported, 70data from Namibia Hearing Care 
Institution, 71Instituto Marques de Valle Flor, 72of babies and young children who received ototoxic drugs, 73journal articles, 74Swanepoel et al. 2013, 75study for 
Charles Nicolles Hospital Tunis with 3260 babies, 76AudioMax Zimbabwe, 77All Ears Cambodia,78National Report of Maternal and Childrens’ Health (2008-2015), 
79National Statistics Office of Georgia, 80data from State Initiative on Disabilities (SID), Kerala, Social Security Mission, Govt. of Kerala: UNHS program with 40 
involved governmental maternity hospitals with ≥100 deliveries per year and 412,164 newborns screened between Oct. 2014 and Aug. 2018, 81Indonesian ORL 
Societies, 82State Welfare Organization of Iran, 83ENT and Head & Neck Research Center, Iran University of Medical Sciences, Tehran, 84National Survey Israel 
data from January 1, 2012, to September 30, 2012, 85data from 2010-2011 National Survey for children enrolled in rehabilitation centers, 86data for children 
enrolled in rehabilitation centers, 87data from 2007-2009 before UNHS was established, 88Survey by the Oto-Rhino-Laryngology Society of Japan, 89Survey by 
Japan Association of Obstetricians and Gynecologists, 90Statistics of Okayama Prefecture, 91UNHS Program Jordan, 92survey from the main audiology clinics in 
Jordan, 93All Ears International DPRK program, 94NHS results from nation-wide low-income class newborns, 95data from national infant health examination 2014,  
96data from 4 government hospitals which run UNHS and 26 hospitals which run targeted screening, 97National Center for Maternal and Child Health, 98Hospital 
admission registry, Neonate Unit, Central Women Hospital, Mandalay, data of 6876 newborns, 99data from hospital records of Institute of Medicine Kathmandu, 
100Oman Ear Care Program, 101Pakistan Demographic and Health Survey, 102Caritas Baby Hospital Bethlehem, internal data, 103pilot study in selected hearing 
screening centers in Metro Manila, Bulacan, and Pampanga, 104Hamad Medical Corporation, 105Habib HS, Abdelgaffar H. Neonatal hearing screening with 
transient evoked otoacoustic emissions in Western Saudi Arabia. Int J Pediatr Otorhinolaryngol. 2005 Jun;69(6):839-42. doi: 10.1016/j.ijporl.2005.01.018 
PMID: 15885338: data from 11986 neonates, 106National Medical Center Tajikistan, 107Institute of Health Uzbekistan, 108Children Hospital No1 HochiMinh City, 
109provincial & local program databases, 110Consejo Nacional para el Desarrollo y la Inclusión de las Personas con Discapacidad, 111data from General Hospital 
of Mexico, México City, DF (based on 5,000 newborns/year), 112López VMM, Chamlati, E, & Berruecos VP (1997) Hearing loss prevention levels in Mexico; a 
multicenter study. Scand Audiol 26 (Suppl 45) 27-32, 1997, 113Centers for Disease Control and Prevention, 114United States Department of Health and Human 
Services, 115data from Registry of Hospital Materno Neonatal, Córdoba, 116Ministério da Saúde, Secretaria de Atenção à Saúde, Departamento de Ações 
Programáticas Estratégicas, Coordenação-Geral de Saúde da Pessoa com Deficiência, data refer only to public health system which comprises 75% of total live 
births in Brazil (2,190,398), NHS performed in private health system not reported, 117data from 146,028 newborns from 17 maternity hosp. in São Paulo, 2011-
2013, 118Hospital Padre Hurtado, Santiago, 119Fundacion Santa Fe de Bogotá, data based on 103,244 newborns from Bogotá, 120database of Caja Costarricen 
de Seguro Social (CCSS, National Children Hospital), 121data of Foundatión Sonrisas Que Escuchan which cover 344 babies at risk and correspond to the 
most babies screened in 2013 in Guatemala, 122based on 700 newborns, 123Statistics Department of Hospital del Niño, Panama City, data of 14,853 newborns 
(20.1% of all newborns born in 2013 in Panama), 124Puerto Rico Department of Health, 125(a) official data provided for some states, (b) well-considered estimates 
for other states based on unofficial reporting and (c) the last-reported data for some other states, 126Centers for Disease Control and Prevention (CDC), US 
Department of Health and Human Services, 127National Newborn Hearing Screening database
Note. No information obtained from the following countries: Andorra, Azerbaijan, San Marino, United Kingdom (Scotland, Wales, Northern Ireland), Burundi, 
Cape Verde, Central African Republic, Comoros, Congo (Brazzaville), Eritrea, Gabon, Liberia, Mauritania, Mauritius, Niger, Sudan, Kingdom of Eswatini, 
Afghanistan, Brunei, Kyrgyzstan, Laos, Lebanon, Maledives, Singapore, Sri Lanka, Yemen, Bahamas, Belize, Cuba, Dominica, Ecuador, Grenada, Guyana, 
Paraguay, Peru, Saint Lucia, Saint Vincent and the Grenadines, Suriname, Venezuela. NIHS was not yet established in the reporting period in the following 
countries: Kosovo, Montenegro, Angola, Benin, Burkina Faso, Chad, Djibouti, Equatorial Guinea, Ethiopia, Gambia, Guinea-Bissau, Lesotho, Libya, Mali, 
Morocco, Mozambique, Rwanda, Senegal, Somalia, South Sudan, Tanzania, Togo, Uganda, Zambia, Bangladesh, Bhutan, Iraq, North Korea, Syria, Timor-Leste, 
Turkmenistan, United Arab Emirates, Antigua and Barbuda, El Salvador, Haiti, Honduras, Saint Kitts and Nevis, Fiji, Kiribati, Nauru, Papua New Guinea, Samoa, 
Solomon Islands, Tonga, Tuvalu, Vanuatu.
